ArticleFoods (Basel, Switzerland)2025
Creating the Equivalence Index to Optimize the Precise Evaluation of Bee Products for Functionally Opposite Components.
Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Bee products, such as honey, bee pollen/bread, bee propolis and royal jelly foraged or secreted by honeybee workers, have been consumed by humans for many years and are important due to their complexity, the large number of them and the endemicity of their constituents. The health-promoting activities of bee products are widely documented all around the world. However, we have noticed a distinct but poorly described feature of bee products: groups of functionally opposite components (FOCs) related to blood sugar level, oxidative stress, cell membrane cholesterol distribution, cell membrane stability, cell membrane curvature, allergic reaction, cellular sodium influx and cardiac apoptosis that exist within these products. We then propose the Equivalence Index in order to overcome the challenges associated with FOCs; this is a concise mathematical model that can be used to optimize the evaluation of quality, determine any underlying mechanisms and provide processing guidance regarding bee products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.